TIF1-γ Positive Dermatomyositis with Spontaneous Muscular Hematoma in the Context of Ovarian Cancer: A Novel Survival Case Report
Zhu Yuan,Chunyan Chen,Shuai Zeng,Zhen Wang,Shili Zhong
DOI: https://doi.org/10.2147/jir.s469401
IF: 4.5
2024-06-19
Journal of Inflammation Research
Abstract:Zhu Yuan, 1, &ast Chunyan Chen, 1, &ast Shuai Zeng, 2 Zhen Wang, 1 Shili Zhong 1 1 Department of Intensive Care Medicine, Army Medical Center of PLA, Chongqing, People's Republic of China; 2 Department of Laboratory Pathology, Unit 32280 of the People's Liberation Army, Leshan City, Sichuan Province, People's Republic of China &astThese authors contributed equally to this work Correspondence: Shili Zhong, Department of Intensive Care Medicine, Army Medical Center of PLA, No. 10 Changjiang Road, Yuzhong District, Chongqing, 400010, People's Republic of China, Tel +86-18323087674, Email Background: Dermatomyositis (DM) represents a group of inflammatory myopathies, with TIF1-γ positive DM strongly associated with malignancies. Spontaneous muscular hematoma in DM patients is exceedingly rare and often prognosticates a severe clinical outcome, especially in the context of concurrent malignancy. Case Presentation: We describe a novel survival case of a patient with TIF1-γ positive DM and an underlying ovarian tumor who developed a spontaneous muscular hematoma. Despite the traditionally poor prognosis of these conditions, the patient survived through a comprehensive treatment regimen. This included targeted chemotherapy for ovarian cancer (Carboplatin and Paclitaxel), alongside corticosteroids, immunoglobulins, and immunosuppressants for DM, as well as component blood transfusions, coagulation correction therapy to control hematoma, and integrated management: nutritional support, lung function exercise, volume management. Results: The integrated treatment strategy stabilized the patient's condition and resolved the hematoma, a significant achievement given the usual high mortality rate of such complications. Conclusion: This case underscores the importance of a multidisciplinary approach in the early diagnosis and treatment of TIF1-γ positive DM with complex comorbidities, including spontaneous muscular hematoma and ovarian cancer. It highlights the potential for favorable outcomes with aggressive and coordinated treatment strategies. Keywords: dermatomyositis, TIF1-γ, spontaneous muscular hematoma, ovarian cancer, multidisciplinary treatment, survival Dermatomyositis (DM) is an autoimmune disorder with systemic involvement characterized by distinctive cutaneous manifestations, including heliotrope rash, Gottron's papules, and nail fold changes, alongside symmetrical proximal muscle weakness, which may lead to complications like dysphagia and respiratory issues. 1 The development of severe complications, notably interstitial lung disease and spontaneous muscle hemorrhage, substantially diminishes the prognosis for DM patients. 2,3 Research has identified various myositis-specific antibodies (MSAs) in DM, each associated with unique clinical phenotypes and prognoses, such as anti-MDA5, anti-TIF1-γ, anti-Mi-2, anti-NXP2, and anti-Jo-1. 4,5 While MSAs typically do not overlap, multiple antibodies can complicate clinical presentation and treatment. 6 TIF1-γ positive DM, categorized as cancer-associated myositis (CAM), demonstrates a significant correlation with malignancies, marking it as a critical risk factor for cancer. 7 Meanwhile, dermatomyositis combined with spontaneous muscle hematoma has a high mortality. 3 This manuscript delves into a rare case of severe spontaneous intramuscular hematoma in a patient with TIF1-γ positive DM against the backdrop of an ovarian tumor, highlighting the intricate interplay between DM and its life-threatening complications. A 50-year-old woman presented to the oncology department with abdominal distension and ascites. Diagnostic efforts, including ascites puncture, cytology, and whole-body PET/MRI, confirmed Stage IVB bilateral ovarian high-grade serous carcinoma (Figure 1). Figure 1 ( A ) PET/CT: FAPI-PET shows increased radioactive uptake in bilateral ovarian adnexal regions. ( B and C ) Pathology and immunohistochemistry show high-grade serous tumor cells in the ovary. The size bar for subfigures ( B and C ) 200μm. Initial chemotherapy with carboplatin and albumin-bound paclitaxel was administered. Concurrent dermatological symptoms prompted a consultation, suggesting dermatomyositis, which was treated with methylprednisolone and diuresis. Despite anticoagulation therapy with low molecular weight heparin due to a hypercoagulable state, the patient's condition is complicated with significant facial edema, dysphagia, and decreased muscle strength, leading to a multidisciplinary team (MDT) review. The MDT's suspicion of dermato -Abstract Truncated-
immunology